During the recently concluded 8th Annual BIO CEO & Investor Conference at the Waldorf-Astoria, the Biotechnology

Industry Organization (BIO) announced this year's winners of the James D. Watson Helix Award for Biotechnology Industry Leadership.

Large Capitalization: Genentech Inc., of South San Francisco, Calif.
Emerging Company/Mid-Capitalization: Alnylam Pharmaceuticals Inc., of Cambridge, Mass.
International: Novo Nordisk Inc., of Princeton, N.J.

"These companies have been selected and recognized as industry leaders by being nominated by their peers. Each firm is devoting its resources to developing cutting-edge science that will lead to breakthrough, life saving therapies. I congratulate them for their success and commitment to saving and improving patient lives," said Jim Greenwood, BIO's president and CEO.

Read more about the award from BIO. You may want to view webcasts of the companies which participated at the conference here.